The Cigna Group (NYSE:CI) Given New $341.00 Price Target at Wells Fargo & Company

The Cigna Group (NYSE:CI) had its target price reduced by analysts at Wells Fargo & Company from $370.00 to $341.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the health services provider’s stock. Wells Fargo & Company‘s price objective suggests a potential upside of 16.53% from the stock’s current price.

Several other research firms have also issued reports on CI. StockNews.com lowered The Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Truist Financial dropped their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald lowered their target price on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Friday. Royal Bank of Canada dropped their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Finally, Morgan Stanley cut their target price on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research note on Friday. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $377.56.

The Cigna Group Stock Up 0.1 %

NYSE CI traded up $0.18 on Tuesday, reaching $292.64. 100,646 shares of the stock traded hands, compared to its average volume of 1,792,447. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The company has a fifty day moving average price of $294.40 and a 200-day moving average price of $324.18. The company has a market cap of $81.40 billion, a price-to-earnings ratio of 23.92, a PEG ratio of 0.97 and a beta of 0.54.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the business earned $6.79 earnings per share. As a group, research analysts forecast that The Cigna Group will post 29.66 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. AMF Tjanstepension AB increased its stake in The Cigna Group by 18.6% during the 3rd quarter. AMF Tjanstepension AB now owns 73,600 shares of the health services provider’s stock worth $25,511,000 after buying an additional 11,550 shares during the period. Czech National Bank boosted its holdings in shares of The Cigna Group by 5.2% in the 3rd quarter. Czech National Bank now owns 56,947 shares of the health services provider’s stock valued at $19,729,000 after buying an additional 2,813 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of The Cigna Group by 45.2% in the 3rd quarter. GAMMA Investing LLC now owns 3,611 shares of the health services provider’s stock valued at $1,251,000 after purchasing an additional 1,124 shares during the last quarter. Bath Savings Trust Co grew its position in shares of The Cigna Group by 3.2% during the third quarter. Bath Savings Trust Co now owns 6,405 shares of the health services provider’s stock worth $2,219,000 after acquiring an additional 200 shares during the last quarter. Finally, Kesler Norman & Wride LLC acquired a new stake in shares of The Cigna Group during the third quarter worth about $692,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.